Allakos Stock Price - ALLK

64.3671
-0.9829 (-1.50%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Allakos Inc ALLK NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.9829 -1.5% 64.3671 63.53 66.84 65.68 65.35 13:38:13
Bid Price Ask Price Spread Spread % News
64.20 64.51 0.31 0.48% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,763 311,355 $ 64.56 $ 20,100,778 350,294 30.32 - 139.99
Last Trade Time Type Quantity Stock Price Currency
13:38:11 100 $ 64.3671 USD

Allakos Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.13B 48.67M $ -43.54M -0.65 - 48.34M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Allakos News

Date Time Source News Article
2/24/202008:06Edgar (US Regulatory)Current Report Filing (8-k)
2/24/202008:00GlobeNewswire Inc.Allakos Announces Multiple Presentations Related to..
2/14/202017:43Edgar (US Regulatory)Statement of Ownership (sc 13g)
2/14/202012:10Edgar (US Regulatory)Statement of Ownership (sc 13g)
2/14/202012:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/14/202006:04Edgar (US Regulatory)Statement of Ownership (sc 13g)
1/07/202018:58Business WireThe Law Offices of Frank R. Cruz Announces Investigation on..

Latest ALLK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALLK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week66.3367.779961.5264.56269,292-1.96-2.96%
1 Month73.7978.263461.5271.15332,658-9.42-12.77%
3 Months95.02139.9961.5299.88457,221-30.65-32.26%
6 Months88.19139.9961.5290.46377,837-23.82-27.01%
1 Year38.26139.9930.3270.97434,37726.1168.24%
3 Years27.20139.9926.0062.98375,55337.17136.64%
5 Years27.20139.9926.0062.98375,55337.17136.64%

Allakos Description

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.
Your Recent History
NASDAQ
ALLK
Allakos
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200225 18:53:14